Types of Diabetic Ketoacidosis
DKA is not formally classified into distinct "types" but rather presents as a single metabolic syndrome that can be categorized by severity (mild, moderate, severe) and by a clinically important variant: classic hyperglycemic DKA versus euglycemic DKA. 1
Classification Framework
By Severity (Biochemical Criteria)
The traditional approach categorizes DKA by severity based on metabolic derangement:
- Mild DKA: pH 7.25-7.30, bicarbonate 15-18 mEq/L
- Moderate DKA: pH 7.00-7.24, bicarbonate 10-15 mEq/L
- Severe DKA: pH <7.00, bicarbonate <10 mEq/L
This severity classification directly impacts mortality risk, with prognosis substantially worsened at extremes of age and in the presence of coma and hypotension 1.
By Glucose Level (Clinical Variant)
Classic (Hyperglycemic) DKA
The traditional presentation includes the diagnostic triad 2:
- Hyperglycemia (blood glucose >250 mg/dL)
- Metabolic acidosis (pH <7.3, bicarbonate <18 mEq/L, anion gap >10 mEq/L)
- Elevated ketones (serum or urine)
This form typically occurs in both type 1 and type 2 diabetes, though type 2 patients usually present with higher glucose levels and milder ketoacidosis 3.
Euglycemic DKA
This increasingly recognized variant presents with ketoacidosis but relatively normal or only mildly elevated glucose levels (often <250 mg/dL) 3, 2.
Key distinguishing features:
- Strongly associated with SGLT-2 inhibitor use, which causes glycosuria that limits hyperglycemia while allowing ketogenesis to proceed 3
- SGLT-2 inhibitors maintain a low baseline level of ketones; any additional stress triggers ketoacidosis without proportional glucose elevation
- More prolonged duration due to the long half-life of SGLT-2 inhibitors 3
- Requires immediate glucose-containing IV fluids to induce endogenous insulin secretion and halt ketogenesis 3
By Diabetes Type
While not a formal classification system, DKA presentation differs:
- Type 1 diabetes: Historically the classic presentation; may be the initial manifestation in 25-40% of cases; typically evolves rapidly (within 24 hours) 1, 4
- Type 2 diabetes: Occurs in at least 34% of cases; usually presents with higher glucose levels and milder acidosis 4
Critical Clinical Pitfall
Hyperglycemia has been de-emphasized in recent diagnostic criteria specifically because of the increasing incidence of euglycemic DKA 2. Clinicians must maintain high suspicion for DKA even with normal or near-normal glucose levels, particularly in patients on SGLT-2 inhibitors. The presence of metabolic acidosis with elevated ketones confirms the diagnosis regardless of glucose level.
The evolution timeframe also differs: classic DKA in type 1 diabetes typically develops within 24 hours, whereas the process leading to hyperosmolar hyperglycemic state (a related but distinct condition) evolves over days to weeks 1.